Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.7K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

4.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.8K
Asthma-I: Introduction01:29

Asthma-I: Introduction

3.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.7K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

3.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.6K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

3.3K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

2.2K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The low flyers: persistent airflow limitation in young adults.

The Lancet. Respiratory medicine·2022
Same author

The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventions.

The Journal of allergy and clinical immunology·2021
Same author

Use of Fractional Exhaled Nitric Oxide to Guide the Treatment of Asthma: An Official American Thoracic Society Clinical Practice Guideline.

American journal of respiratory and critical care medicine·2021
Same author

Factors Associated with Persistence of Severe Asthma from Late Adolescence to Early Adulthood.

American journal of respiratory and critical care medicine·2021
Same author

PrecISE: Precision Medicine in Severe Asthma: An adaptive platform trial with biomarker ascertainment.

The Journal of allergy and clinical immunology·2021
Same author

Lung mechanical properties distinguish children with asthma with normal and diminished lung function.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2020
Same journal

Biosimilars in allergology: an outline in pediatric patients.

Current opinion in allergy and clinical immunology·2026
Same journal

The immunogenetic landscape of systemic lupus erythematosus.

Current opinion in allergy and clinical immunology·2026
Same journal

Circadian control of innate immunity: molecular mechanisms and implications for allergic disorders.

Current opinion in allergy and clinical immunology·2026
Same journal

Probiotics in allergic disease: from adjunct supplement to immune-modifying strategy (2026 update).

Current opinion in allergy and clinical immunology·2026
Same journal

Updates on drug-induced anaphylaxis in children.

Current opinion in allergy and clinical immunology·2026
Same journal

Beta-lactam de-labelling as a core antimicrobial stewardship strategy in the era of the antimicrobial resistance pandemic: a narrative review.

Current opinion in allergy and clinical immunology·2026
See all related articles

Related Experiment Video

Updated: Mar 26, 2026

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

41.8K

Asthma phenotypes in childhood.

Monica B Reddy1, Ronina A Covar

  • 1aNational Jewish Health, Department of Pediatrics bUniversity of Colorado Denver Health Sciences Center, Denver, Colorado, USA.

Current Opinion in Allergy and Clinical Immunology
|February 10, 2016
PubMed
Summary
This summary is machine-generated.

Recent research reveals new childhood asthma phenotypes identified through statistical analysis. Understanding these diverse asthma presentations is crucial for tailored treatments and improved prognoses in children.

More Related Videos

Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

29.0K
Cultivate Primary Nasal Epithelial Cells from Children and Reprogram into Induced Pluripotent Stem Cells
12:08

Cultivate Primary Nasal Epithelial Cells from Children and Reprogram into Induced Pluripotent Stem Cells

Published on: March 10, 2016

11.9K

Related Experiment Videos

Last Updated: Mar 26, 2026

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

41.8K
Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

29.0K
Cultivate Primary Nasal Epithelial Cells from Children and Reprogram into Induced Pluripotent Stem Cells
12:08

Cultivate Primary Nasal Epithelial Cells from Children and Reprogram into Induced Pluripotent Stem Cells

Published on: March 10, 2016

11.9K

Area of Science:

  • Pediatric Pulmonology
  • Allergy and Immunology
  • Respiratory Medicine

Background:

  • Childhood asthma is a complex respiratory condition with varied clinical presentations.
  • Phenotyping aims to classify asthma into distinct subgroups for better understanding and management.
  • Previous research has established early childhood asthma phenotypes based on onset and wheezing patterns.

Purpose of the Study:

  • To review recent literature (past 18 months) on childhood asthma phenotypes.
  • To highlight key findings and compare new studies with prior research in this field.
  • To synthesize current understanding of asthma heterogeneity in children.

Main Methods:

  • Literature review of studies published within the last 18 months.
  • Analysis of research employing statistical methods like cluster and latent class analysis.
  • Inclusion of studies investigating immunologic, physiologic, and genetic correlates.

Main Results:

  • Identification of novel asthma phenotypes using advanced statistical techniques.
  • Evaluation of outcomes and risk factors for established early childhood asthma phenotypes.
  • Exploration of immunologic, physiologic, and genetic associations with different asthma phenotypes.
  • Characterization of subphenotypes within severe childhood asthma.

Conclusions:

  • Childhood asthma is inherently heterogeneous, necessitating continued phenotyping research.
  • Understanding diverse asthma presentations, risk factors, and outcomes holds significant therapeutic and prognostic value.
  • Further investigation into the immunopathology and genetics of childhood asthma phenotypes is essential for personalized medicine.